À propos
Dr Fahad Ibnshamsah is a highly respected Consultant Medical Oncologist and Internal Medicine Specialist. He is dedicated to providing comprehensive and compassionate care to patients facing complex oncological diagnoses. With a strong commitment to advancing cancer treatment, he combines evidence-based medicine with a reassuring approach, ensuring that each patient receives a personalised treatment plan tailored to their specific needs. He also serves as an Assistant Professor of Internal Medicine, sharing his extensive clinical expertise with the next generation of medical professionals.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Fahad Ibnshamsah
Formation et études
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Oncologie
Carrière et postes
-
2021-09–2022-08 Junior consultant
Licences et assurance
Licences médicales
SA — Organización Médica Colegial de España (OMC)
Certifications du conseil
European Board of Oncologie
Assurance responsabilité professionnelle :
HDI Global · 3,000,000 EUR couverture · No claims on file
Procédures réalisées
| Procédure | Code | Total à vie |
|---|---|---|
| GP consultation | 99213 | 956 |
| Annual physical exam | 99395 | 266 |
| Vaccination administration | 90471 | 2,826 |
| Minor procedure (skin) | 17110 | 693 |
Services et tarifs
| Service | Durée | Modalité | Prix |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 180.00 EUR |
Cabinet, équipe & en pratique
Vidéos
Recherche et publications
indice h : 5 · i10 : 7
-
Long-term follow-up of Oncologie across SA
DOI: 10.8710/euroclin.2026.0 · PMID: 37979660 · cité par 180
-
Validation of clinical scoring in Oncologie
DOI: 10.5738/euroclin.2025.1 · PMID: 31282003 · cité par 102
-
Long-term follow-up of Oncologie across SA
DOI: 10.9519/euroclin.2024.2 · PMID: 33838956 · cité par 16
-
Validation of clinical scoring in Oncologie
DOI: 10.4283/euroclin.2023.3 · PMID: 39972240 · cité par 162
Conférences invitées
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · Dammam · 2023 · oral abstract
Récompenses et adhésions
Récompenses
- 🏆 Top-rated Oncologie — Dammam · EuroClinics Patient Choice · 2025 · regional
Adhésions à des sociétés
- WONCA Europe — Family Doctors — Member · Depuis 2022
- national college of family doctors — Member · Depuis 2022
- European Union of Medical Specialists (UEMS) — Member · Depuis 2022
Articles de ce médecin
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Pour les patients internationaux
- Coordinateur
- Patient liaison · fahad.ibnshamsah@euroclinics.example
Emplacement
1 baliseAvis des patients
Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
Avis récents
-
★★★★★ ✓ Vérifié Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Vérifié Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Vérifié Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.